Adipocyte-based high throughput screening for anti-obesity drug discovery: Current status and future perspectives
Drug discovery for obesity treatment, particularly bodily slimming, is a topic of timely importance that requires continued investigation, as the current therapies have limited efficacy with many adverse effects. Obesity is associated with adipose tissue expansion, where the size and number of adipo...
Main Author: | Leo Tsui |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | SLAS Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2472555222136853 |
Similar Items
-
High-throughput screening in drug discovery /
by: Huser, Jorg
Published: (2006) -
Organoids in high-throughput and high-content screenings
by: Franziska L. Lampart, et al.
Published: (2023-03-01) -
Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models
by: Morteza Chalabi Hajkarim, et al.
Published: (2022-02-01) -
Differential analyte derivatization enables unbiased MALDI-TOF-based high-throughput screening: A proof-of-concept study for the discovery of catechol-o-methyltransferase inhibitors
by: Martin Winter, et al.
Published: (2022-07-01) -
High-Throughput Screening Platforms in the Discovery of Novel Drugs for Neurodegenerative Diseases
by: Hasan Aldewachi, et al.
Published: (2021-02-01)